1.11
-0.05(-4.31%)
Currency In USD
| Previous Close | 1.16 |
| Open | 1.17 |
| Day High | 1.17 |
| Day Low | 1.1 |
| 52-Week High | 3.2 |
| 52-Week Low | 1 |
| Volume | 757,707 |
| Average Volume | 665,230 |
| Market Cap | 6.44M |
| PE | -0.66 |
| EPS | -1.68 |
| Moving Average 50 Days | 1.98 |
| Moving Average 200 Days | 2.21 |
| Change | -0.05 |
If you invested $1000 in BioCardia, Inc. (BCDA) 10 years ago, it would be worth $2.85 as of September 23, 2025 at a share price of $1.11. Whereas If you bought $1000 worth of BioCardia, Inc. (BCDA) shares 5 years ago, it would be worth $10.24 as of September 23, 2025 at a share price of $1.11.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
BioCardia Announces Positive Preliminary Clinical Consultation with Japan Pharmaceutical and Medical Device Agency on Cell Therapy for Ischemic Heart Failure
GlobeNewswire Inc.
Yesterday at 12:00 PM GMT
SUNNYVALE, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announces it has had a positive preliminary clin
BioCardia Announces Pricing of Up To $12 Million Public Offering
GlobeNewswire Inc.
Sep 18, 2025 1:15 PM GMT
$6 million upfront with up to an additional $6 million of potential aggregate gross proceeds upon the exercise in full of short-term warrantsSUNNYVALE, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA] (“BioCardia” or the “C
BioCardia Announces CardiAMP Chronic Myocardial Ischemia Trial Top Line Data of Roll-in Cohort Show Improved Exercise Tolerance and Reduced Angina Episodes at Six-Month Primary Follow-up
GlobeNewswire Inc.
Sep 18, 2025 11:00 AM GMT
SUNNYVALE, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ: BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the primary endpoint results of